BCL6-IN-5 |
| Katalog-Nr.GC60626 |
BCL6-IN-5 ist ein potenter BCL6-Inhibitor, der aus dem Patent WO2018215801A1, Beispiel 1n, hervorgeht, und hat einen pIC50 von 5,82.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2253878-09-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
BCL6-IN-5 is a potent BCL6 inhibitor exacted from patent WO2018215801A1, example 1n, has a pIC50 of 5.82[1].
[1]. Benjamin Richard BELLENIE, et al. Benzimidazolone derived inhibitors of bcl6. WO2018215801A1.
Review for BCL6-IN-5
Average Rating: 5 (Based on Reviews and 21 reference(s) in Google Scholar.)
Review for BCL6-IN-5
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *